F
Frank Rosenbauer
Researcher at University of Münster
Publications - 55
Citations - 7188
Frank Rosenbauer is an academic researcher from University of Münster. The author has contributed to research in topics: Transcription factor & Haematopoiesis. The author has an hindex of 30, co-authored 49 publications receiving 6468 citations. Previous affiliations of Frank Rosenbauer include Max Delbrück Center for Molecular Medicine & Harvard University.
Papers
More filters
Journal ArticleDOI
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Katrin Kierdorf,Daniel Erny,Tobias Goldmann,Victor Sander,Christian Schulz,Elisa Gomez Perdiguero,Peter Wieghofer,Annette Heinrich,Pia Riemke,Christoph Hölscher,Dominik N. Müller,Bruno Luckow,Thomas Brocker,Katharina Debowski,Günter Fritz,Ghislain Opdenakker,Andreas Diefenbach,Knut Biber,Knut Biber,Mathias Heikenwalder,Frederic Geissmann,Frank Rosenbauer,Marco Prinz +22 more
TL;DR: It is found that mouse microglia were derived from primitive c-kit+ erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception and microgliogenesis was not only dependent on the transcription factor Pu.1, but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required.
Journal ArticleDOI
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.
Thomas Holtschke,Jürgen Löhler,Yuka Kanno,Thomas Fehr,N.A. Giese,Frank Rosenbauer,Jing Lou,Klaus-Peter Knobeloch,Lucia Gabriele,Jeffrey F. Waring,Martin F. Bachmann,Rolf M. Zinkernagel,Herbert C. Morse,Keiko Ozato,Ivan Horak +14 more
TL;DR: A novel role for ICSBP is suggested in regulating the proliferation and differentiation of hematopoietic progenitor cells in mice with a null mutation of ICS BP.
Journal ArticleDOI
Transcription factors in myeloid development: balancing differentiation with transformation.
Frank Rosenbauer,Daniel G. Tenen +1 more
TL;DR: Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates, and therapies designed to restore defective transcription factor functions are an attractive option in the treatment ofMyeloid and other human cancers.
Journal ArticleDOI
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Frank Rosenbauer,Katharina Wagner,Jeffery L. Kutok,Hiromi Iwasaki,Michelle M. Le Beau,Yutaka Okuno,Koichi Akashi,Steven Fiering,Daniel G. Tenen +8 more
TL;DR: Results suggest that tightly graded reduction, rather than complete loss, of a lineage-indispensable transcription factor can induce AML.
Journal ArticleDOI
DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
Ann-Marie Bröske,Lena Vockentanz,Shabnam Kharazi,Matthew R. Huska,Elena Mancini,Marina Scheller,Christiane Kuhl,Andreas Enns,Marco Prinz,Rudolf Jaenisch,Claus Nerlov,Achim Leutz,Miguel A. Andrade-Navarro,Sten Eirik W. Jacobsen,Sten Eirik W. Jacobsen,Frank Rosenbauer +15 more
TL;DR: This work shows that alternative functional programs of hematopoietic stem cells (HSCs) are governed by gradual differences in methylation levels and identifies DNA methylation as an essential epigenetic mechanism to protect stem cells from premature activation of predominant differentiation programs.